News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

uniQure Announces Confidential Submission of Draft Registration Statement for Initial Public Offering


11/11/2013 11:36:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AMSTERDAM, The Netherlands, Nov. 11, 2013 (GLOBE NEWSWIRE) -- uniQure B.V., a leader in human gene therapy, today announced that it has confidentially submitted a registration statement on Form F-1 to the U.S. Securities and Exchange Commission ("SEC") relating to a possible initial public offering of its ordinary shares. The number of ordinary shares to be offered and the price range for the offering have not yet been determined.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
uniQure
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES